共 697 条
[1]
Koethe JR(2016)Rising obesity prevalence and weight gain among adults starting antiretroviral therapy in the United States and Canada AIDS Res Hum Retroviruses 32 50-58
[2]
Jenkins CA(2020)Weight gain following initiation of antiretroviral therapy: risk factors in randomized comparative clinical trials Clin Infect Dis 71 1379-1389
[3]
Lau B(2020)Weight gain among treatment-naive persons with HIV starting integrase inhibitors compared to non-nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada J Int AIDS Soc 23 e25484-811
[4]
Shepherd BE(2018)Type 2 diabetes prevalence and its risk factors in HIV: a cross-sectional study PLoS ONE 13 e0194199-1543
[5]
Justice AC(2017)Is diabetes prevalence higher among HIV-infected individuals compared with the general population? Evidence from MMP and NHANES 2009–2010 BMJ Open Diabetes Res Care 5 e000304-492
[6]
Tate JP(2009)Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A: D Study) Circulation 119 805-441
[7]
Buchacz K(2017)New-onset diabetes in HIV-treated adults: predictors, long-term renal and cardiovascular outcomes AIDS 31 1535-459
[8]
Napravnik S(2012)Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder Neurology 78 485-1614
[9]
Mayor AM(2018)Incidence and risk factors for prediabetes and diabetes mellitus among HIV-infected adults on antiretroviral therapy: a systematic review and meta-analysis Epidemiol 29 431-1859
[10]
Horberg MA(2018)High rates of incident diabetes and prediabetes are evident in men with treated HIV followed for 11 years AIDS 32 451-236